These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34145188)

  • 1. Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?
    Weng J; Fairbairn N; Sutherland C; Johnson C; Nolan S
    J Addict Med; 2022 May-Jun 01; 16(3):258-260. PubMed ID: 34145188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G; Bowles JM; Mansoor M; Werb D; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):14. PubMed ID: 36869358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
    Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
    JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Treatment of Opioid Use Disorder.
    Bell J; Strang J
    Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern.
    Alho H; Dematteis M; Lembo D; Maremmani I; Roncero C; Somaini L
    Int J Drug Policy; 2020 Feb; 76():102616. PubMed ID: 31855706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling the overdose crisis: The role of safe supply.
    Ivsins A; Boyd J; Beletsky L; McNeil R
    Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada.
    Young S; Kolla G; McCormack D; Campbell T; Leece P; Strike C; Srivastava A; Antoniou T; Bayoumi AM; Gomes T
    Int J Drug Policy; 2022 Apr; 102():103601. PubMed ID: 35124413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
    Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
    PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
    Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
    Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada.
    Olding M; Ivsins A; Mayer S; Betsos A; Boyd J; Sutherland C; Culbertson C; Kerr T; McNeil R
    Am J Public Health; 2020 Jun; 110(6):833-835. PubMed ID: 32298171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
    Glegg S; McCrae K; Kolla G; Touesnard N; Turnbull J; Brothers TD; Brar R; Sutherland C; Le Foll B; Sereda A; Goyer MÈ; Rai N; Bernstein S; Fairbairn N
    Int J Drug Policy; 2022 Aug; 106():103742. PubMed ID: 35679695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revising our attitudes towards agonist medications and their diversion in a time of pandemic.
    Del Pozo B; Rich JD
    J Subst Abuse Treat; 2020 Dec; 119():108139. PubMed ID: 33138924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Cascade of Care for responding to the opioid epidemic.
    Williams AR; Nunes EV; Bisaga A; Levin FR; Olfson M
    Am J Drug Alcohol Abuse; 2019; 45(1):1-10. PubMed ID: 30675818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.